← FDA Drug Approvals (Drugs@FDA)
PEMETREXED
NDA · New Drug Application · Sponsor: SHILPA · Approved 2023-05-22
Drug application
- FDA Application #
NDA215179
- Application type
- New Drug Application
- Brand name
- PEMETREXED
- Generic name
- PEMETREXED DISODIUM
- Active ingredients
- PEMETREXED DISODIUM
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- SHILPA
- Manufacturer
- Amneal Pharmaceuticals LLC
- First approval
- 2023-05-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown